Intelligent Bio SolutionsINBS -2.26%49 Net Debt Paydown Yield % is -15.44% as of Jul. 12, 2026. GuruFocus rates INBS with a GF Score™ of 49/100 and a GF Value™ of $2.60 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 772 Medical Devices & Instruments companies, Intelligent Bio Solutions ranks worse than 92.62% on this metric.
Net Debt Paydown Yield % is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. It is a measure of a company's willingness and ability to reduce its debt.
As of today, Intelligent Bio Solutions's Net Debt Paydown Yield % was -15.44%.
Intelligent Bio Solutions (NAS:INBS) Net Debt Paydown Yield % Explanation
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced. In other words, it is a measure of the willingness and ability of a firm's management to pay down debt. Companies that have high debt paydown yields indicate that they are more aggressive with paying down debt.
In the calculation of Net Debt Paydown Yield %, we use the reductions of TTM average total debt one-year-ago and TTM average total debt at present, divided by its Market Cap.
Intelligent Bio Solutions Net Debt Paydown Yield % Related Terms
Intelligent Bio Solutions Net Debt Paydown Yield % Historical Data
* Premium members only.
The historical data trend for Intelligent Bio Solutions's Net Debt Paydown Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Intelligent Bio Solutions Net Debt Paydown Yield % Chart
INBS vs ITOC, WOK, BMRA: Net Debt Paydown Yield % Comparison
For the Medical Devices subindustry, Intelligent Bio Solutions's Net Debt Paydown Yield %, along with its competitors' market caps and Net Debt Paydown Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Intelligent Bio Solutions Net Debt Paydown Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Intelligent Bio Solutions's Net Debt Paydown Yield % distribution charts can be found below:
* The bar in red indicates where Intelligent Bio Solutions's Net Debt Paydown Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Net Debt Paydown Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
What does a Net Debt Paydown Yield % of -15.44% mean?
Intelligent Bio Solutions (INBS) has a Net Debt Paydown Yield % of -15.44% as of Jul. 12, 2026. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Intelligent Bio Solutions and its competitors. According to the industry distribution chart, Intelligent Bio Solutions ranks #715 out of 772 companies in the Medical Devices & Instruments industry, placing it in the top 92.6%.
Is Intelligent Bio Solutions' Net Debt Paydown Yield % too high?
Intelligent Bio Solutions' current Net Debt Paydown Yield % is -15.44%. Based on the distribution chart, Intelligent Bio Solutions ranks #715 out of 772 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Intelligent Bio Solutions has a GF Score™ of 49/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Intelligent Bio Solutions' Net Debt Paydown Yield % compare to ITOC and WOK?
According to the Medical Devices & Instruments industry distribution chart, Intelligent Bio Solutions ranks #715 out of 772 companies for Net Debt Paydown Yield %. This places Intelligent Bio Solutions in the lower half of its industry. The industry median Net Debt Paydown Yield % is 0.01. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Debt Paydown Yield % for a Medical Devices & Instruments company?
The median Net Debt Paydown Yield % among Medical Devices & Instruments companies is 0.01, based on 772 companies in the industry. Companies in the top quartile (top 25%) have a Net Debt Paydown Yield % significantly above this median, while those in the bottom quartile fall well below. However, Net Debt Paydown Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Debt Paydown Yield % mean?
A high Net Debt Paydown Yield % can signal that a stock is expensive relative to its fundamentals. Net Debt Paydown Yield is a metric that evaluates the total amount of debt a company has paid in relation to its market capitalization. This metric provides insight into a company's willingness and ability to reduce its debt using free cash flow. View historical data on Intelligent Bio Solutions and its competitors. For the Medical Devices & Instruments industry, the median Net Debt Paydown Yield % is 0.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intelligent Bio Solutions's current Net Debt Paydown Yield % is -15.44%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intelligent Bio Solutions stock overvalued right now?
Based on GuruFocus' analysis, Intelligent Bio Solutions (INBS) is currently considered Modestly Undervalued. The stock's GF Value™ is $2.60, compared to a current price of $2.16 — trading 16.9% below its estimated fair value. The current Net Debt Paydown Yield % is -15.44%. Intelligent Bio Solutions' overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Debt Paydown Yield % calculated?
Net Debt Paydown Yield % is calculated from a company's financial statements. For Intelligent Bio Solutions (INBS), the current Net Debt Paydown Yield % is -15.44% as of Jul. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Intelligent Bio Solutions (INBS) Overvalued in 2026?
Based on GuruFocus' analysis, Intelligent Bio Solutions stock appears to be undervalued.
The current stock price of $2.16 is trading 16.9% below its estimated GF Value™ of $2.60.
GuruFocus considers Intelligent Bio Solutions to be Modestly Undervalued.
Key valuation signals for INBS:
Net Debt Paydown Yield %: -15.44%
GF Value™: $2.60 vs. price of $2.16 (16.9% below fair value)
No single metric tells the full story. See the INBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company operates through new reportable segments: United Kingdom; Asia Pacific (APAC); Americas; and Rest of World, of which United Kingdom derives maximum revenue.
49GF Score
Get the complete analysis for INBS
Net Debt Paydown Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INBS has been successfully added to your 
